- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07578090
Regional Innovation in Chronic Disease and Elderly Care
A Regional Integrated Care Innovation Program for Cardiometabolic Health, Pulmonary-Circulatory Disease Management, and Elderly Support
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Background: Hypertension, diabetes, and dyslipidemia are major risk factors for cardiovascular disease, with prevalence continuing to rise in Taiwan. These conditions are closely associated with shared risk factors such as aging, obesity, and smoking. The districts of Xinzhuang, Wugu, and Taishan in New Taipei City are densely populated and have a significant aging population. Environmental changes such as urbanization and air pollution pose threats to residents' cardiopulmonary health. Exercise interventions have been proven effective in improving blood pressure, blood glucose, and lipid profiles, as well as enhancing cardiopulmonary function and quality of life. Therefore, implementing structured and personalized exercise promotion programs in the community is of great importance for disease control and health promotion among populations with metabolic syndrome.
Methods: Participants will first undergo a one-month in-hospital conventional exercise training program, followed by an eleven-month home-based exercise intervention. During and after the intervention period, physical activity assessments and biochemical blood tests will be conducted.
Effect: This project aims to establish a community-based health promotion model for individuals at risk of hypertension, diabetes, and hyperlipidemia, centered on exercise interventions and lifestyle modifications. Through assessment, stratification, intervention, and outcome tracking, the project seeks to enhance health behaviors, self-management skills, and cardiopulmonary function in at-risk populations, thereby slowing disease progression and reducing healthcare resource utilization. The research findings will be submitted to relevant domestic and international academic conferences and SCI journals to increase Taiwan's international visibility in the fields of geriatric and "three highs" care. Additionally, the project will cultivate a new generation of healthcare professionals equipped with practical skills in preventive medicine and health promotion, strengthening interprofessional teamwork and community outreach capacity.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Ke-Yun Chao, PhD
- Numéro de téléphone: +886-905-301-879
- E-mail: C00152@mail.fjuh.fju.edu.tw
Lieux d'étude
-
-
-
New Taipei City, Taïwan, 24352
- Recrutement
- Fu Jen Catholic University Hospital, Fu Jen Catholic University
-
Contact:
- Ke-Yun Chao, PhD
- Numéro de téléphone: +886-905-301-879
- E-mail: ck_qq@hotmail.con
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Participants with hypertension, hyperglycemia, or hyperlipidemia who meet at least one of these criteria are eligible for enrollment.
Exclusion Criteria:
- Age under 18 years
- Patients diagnosed with neuromuscular disorders
- Inability to perform cardiopulmonary exercise testing
- Refusal to participate in the study
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
appendicular skeletal muscle mass index
Délai: From enrollment to the end of intervention at 12 months
|
appendicular skeletal muscle mass (ASM) divided by height squared; low muscle mass is defined as ASMI < 7.0 kg/m² in men and < 5.7 kg/m² in women
|
From enrollment to the end of intervention at 12 months
|
|
six minute walk test
Délai: From enrollment to the end of intervention at 12 months
|
functional performance; higher scores mean a better outcome
|
From enrollment to the end of intervention at 12 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Ke-Yun Chao, PhD, Fu Jen Catholic University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- FJUH114523
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .